Skip to main content
logo
NervGen Pharma Corp. (NGEN)
NASDAQ: NGEN · Real-Time Price · USD
1.910
-0.010 (-0.52%)
At close: Sep 30, 2026, 4:00 PM EDT
1.880
-0.030 (-1.57%)
After-hours: Sep 30, 2026, 6:20 PM EDT

NervGen Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
2054461531227097
Market Cap Growth
18.87%190.81%26.05%74.14%-27.73%58.13%
Enterprise Value
1444381381115090
Last Close Price
1.915.602.182.041.192.13

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
16.71175.7785.59-79.937.027.27
P/TBV Ratio
17.26199.21104.44-7.257.48

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-0.000.04-0.100.02-
Net Debt / Equity Ratio
-5.02-6.34-6.665.71-1.65-1.01
Net Debt / EBITDA Ratio
2.690.880.680.650.971.33
Net Debt / FCF Ratio
3.381.131.021.011.252.05
Quick Ratio
1.191.121.050.792.2015.76
Current Ratio
1.231.161.130.832.2716.16
Return on Equity (ROE)
-757.48%-1457.57%-8546.24%-390.89%-136.87%-111.94%
Return on Assets (ROA)
-37.70%-73.42%-96.17%-59.88%-68.90%-65.17%
Return on Capital Employed (ROCE)
-187.00%-721.30%-973.90%933.90%-168.60%-76.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-21.24%-7.22%-11.00%-13.94%-21.93%-10.41%
FCF Yield
-8.78%-3.19%-7.64%-7.04%-18.84%-6.77%
Buyback Yield / Dilution
-13.43%-7.44%-13.55%-12.61%-34.00%-22.35%